Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02467400 · ClinicalTrials.gov registry record · Early Phase 1
Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 165
- Enrollment target
NCT02467400: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT02467400 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 165 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (211% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02467400, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 165 participants
- Enrollment target
Study Summary
This study is designed to answer the question as to whether the sympathetic nervous system is an important determinant of bone metabolism in humans.
Primary Outcome
Serum bone formation marker (PINP)/serum bone resorption marker (CTX)
Interventions
- DRUG placebo
- DRUG Atenolol
- DRUG Propranolol
- DRUG Nebivolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2018-04-01 |
| Phase | Early Phase 1 |
What the finished NCT02467400 record still lists
NCT02467400 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (211% higher).
The record links to 0 conditions, and to 4 interventions - of which placebo is the first listed.
NCT02467400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02467400 about?
NCT02467400 is a clinical study titled "Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism". This study is designed to answer the question as to whether the sympathetic nervous system is an important determinant of bone metabolism in humans.
What is the current status of trial NCT02467400?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 165 participants. The study started on 2015-07-01. Estimated completion is 2018-04-01.
What interventions are being tested in trial NCT02467400?
The interventions under investigation include: placebo (DRUG), Atenolol (DRUG), Propranolol (DRUG), Nebivolol (DRUG).
Who is sponsoring clinical trial NCT02467400?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02467400's enrollment target sits among peer trials
165 80th of 2000 higher than 1,919 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI